Today’s global drug market faces more pressure than ever before. Pharmaceutical companies deal with higher development costs, tougher regulations, stricter pricing, and more competition from generics and biosimilars. Meanwhile, patients, payers, and governments want quicker access to safe and effective treatments. These factors are changing how companies plan, develop, launch, and manage products over time.

To succeed, companies need to know what causes market pressure and how it shapes their decisions. They also have to adjust their strategies while keeping quality, safety, and compliance intact.